Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping

Rogier Oldenburg; K Kroeze-Jansema; EJ Meijers-Heijboer; CJ van Asperen; N Hoogerbrugge; I van Leeuwen; HFA Vasen; AM (Anne-Marie) Cleton-Jansen; Jaco Kraan; JJ Houwing-Duistermaat; H Morreau; CJ Cornelisse; P Devilee

doi:10.1158/1078-0432.CCR-05-2230

Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping

Rogier Oldenburg, K Kroeze-Jansema, EJ Meijers-Heijboer, CJ van Asperen, N Hoogerbrugge, I van Leeuwen, HFA Vasen, AM (Anne-Marie) Cleton-Jansen, Jaco Kraan, JJ Houwing-Duistermaat, H Morreau, CJ Cornelisse, P Devilee

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1693-1700
Number of pages	8
Journal	Clinical Cancer Research
Volume	12
Issue number	6
DOIs	https://doi.org/10.1158/1078-0432.CCR-05-2230
Publication status	Published - 2006

Access to Document

10.1158/1078-0432.CCR-05-2230

http://hdl.handle.net/1765/55630

Cite this

Oldenburg, R., Kroeze-Jansema, K., Meijers-Heijboer, EJ., van Asperen, CJ., Hoogerbrugge, N., van Leeuwen, I., Vasen, HFA., Cleton-Jansen, AM., Kraan, J., Houwing-Duistermaat, JJ., Morreau, H., Cornelisse, CJ., & Devilee, P. (2006). Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. Clinical Cancer Research, 12(6), 1693-1700. https://doi.org/10.1158/1078-0432.CCR-05-2230

Oldenburg, Rogier ; Kroeze-Jansema, K ; Meijers-Heijboer, EJ ; van Asperen, CJ ; Hoogerbrugge, N ; van Leeuwen, I ; Vasen, HFA ; Cleton-Jansen, AM (Anne-Marie) ; Kraan, Jaco ; Houwing-Duistermaat, JJ ; Morreau, H ; Cornelisse, CJ ; Devilee, P. / Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 6. pp. 1693-1700.

@article{99d4531f4fbd42d9923256ebd7a6e8b9,

title = "Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping",

author = "Rogier Oldenburg and K Kroeze-Jansema and EJ Meijers-Heijboer and {van Asperen}, CJ and N Hoogerbrugge and {van Leeuwen}, I and HFA Vasen and Cleton-Jansen, {AM (Anne-Marie)} and Jaco Kraan and JJ Houwing-Duistermaat and H Morreau and CJ Cornelisse and P Devilee",

year = "2006",

doi = "10.1158/1078-0432.CCR-05-2230",

language = "Undefined/Unknown",

volume = "12",

pages = "1693--1700",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

Oldenburg, R, Kroeze-Jansema, K, Meijers-Heijboer, EJ, van Asperen, CJ, Hoogerbrugge, N, van Leeuwen, I, Vasen, HFA, Cleton-Jansen, AM, Kraan, J, Houwing-Duistermaat, JJ, Morreau, H, Cornelisse, CJ & Devilee, P 2006, 'Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping', Clinical Cancer Research, vol. 12, no. 6, pp. 1693-1700. https://doi.org/10.1158/1078-0432.CCR-05-2230

Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. / Oldenburg, Rogier; Kroeze-Jansema, K; Meijers-Heijboer, EJ; van Asperen, CJ; Hoogerbrugge, N; van Leeuwen, I; Vasen, HFA; Cleton-Jansen, AM (Anne-Marie); Kraan, Jaco; Houwing-Duistermaat, JJ; Morreau, H; Cornelisse, CJ; Devilee, P.

In: Clinical Cancer Research, Vol. 12, No. 6, 2006, p. 1693-1700.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping

AU - Oldenburg, Rogier

AU - Kroeze-Jansema, K

AU - Meijers-Heijboer, EJ

AU - van Asperen, CJ

AU - Hoogerbrugge, N

AU - van Leeuwen, I

AU - Vasen, HFA

AU - Cleton-Jansen, AM (Anne-Marie)

AU - Kraan, Jaco

AU - Houwing-Duistermaat, JJ

AU - Morreau, H

AU - Cornelisse, CJ

AU - Devilee, P

PY - 2006

Y1 - 2006

U2 - 10.1158/1078-0432.CCR-05-2230

DO - 10.1158/1078-0432.CCR-05-2230

M3 - Article

VL - 12

SP - 1693

EP - 1700

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -